Human Genome Epidemiology Literature Finder
Records 1 - 15 (of 15 Records) |
Query Trace: Thrombocytopenia and JAK2[original query] |
---|
Identification of patients with poorer survival in primary myelofibrosis based on the burden of JAK2V617F mutated allele. Blood 2009 Aug 114 (8): 1477-83. Guglielmelli Paola, Barosi Giovanni, Specchia Giorgina, Rambaldi Alessandro, Lo Coco Francesco, Antonioli Elisabetta, Pieri Lisa, Pancrazzi Alessandro, Ponziani Vanessa, Delaini Federica, Longo Giovanni, Ammatuna Emanuele, Liso Vincenzo, Bosi Alberto, Barbui Tiziano, Vannucchi Alessandro |
Safety and efficacy of TG101348, a selective JAK2 inhibitor, in myelofibrosis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 1 29 (7): 789-96. Pardanani Animesh, Gotlib Jason R, Jamieson Catriona, Cortes Jorge E, Talpaz Moshe, Stone Richard M, Silverman Michael H, Gilliland D Gary, Shorr Jolene, Tefferi Ayal |
Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis. Blood 2014 Aug 124 (7): 1062-9. Rumi Elisa, Pietra Daniela, Pascutto Cristiana, Guglielmelli Paola, Martínez-Trillos Alejandra, Casetti Ilaria, Colomer Dolors, Pieri Lisa, Pratcorona Marta, Rotunno Giada, Sant'Antonio Emanuela, Bellini Marta, Cavalloni Chiara, Mannarelli Carmela, Milanesi Chiara, Boveri Emanuela, Ferretti Virginia, Astori Cesare, Rosti Vittorio, Cervantes Francisco, Barosi Giovanni, Vannucchi Alessandro M, Cazzola Mario, |
A compendium of cytogenetic abnormalities in myelofibrosis: molecular and phenotypic correlates in 826 patients. British journal of haematology 2015 Apr 169 (1): 71-6. Wassie Emnet, Finke Christy, Gangat Naseema, Lasho Terra L, Pardanani Animesh, Hanson Curtis A, Ketterling Rhett P, Tefferi Ayal |
Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study. Blood 2014 Apr 123 (14): 2157-60. Guglielmelli Paola, Biamonte Flavia, Rotunno Giada, Artusi Valentina, Artuso Lucia, Bernardis Isabella, Tenedini Elena, Pieri Lisa, Paoli Chiara, Mannarelli Carmela, Fjerza Rajmonda, Rumi Elisa, Stalbovskaya Viktoriya, Squires Matthew, Cazzola Mario, Manfredini Rossella, Harrison Claire, Tagliafico Enrico, Vannucchi Alessandro M, , |
Disease characteristics and outcomes in younger adults with primary and secondary myelofibrosis. British journal of haematology 2016 Jun . Beauverd Yan, Alimam Samah, McLornan Donal P, Radia Deepti H, Harrison Claire |
Momelotinib therapy for myelofibrosis: a 7-year follow-up. Blood cancer journal 2018 3 8 (3): 29. Tefferi Ayalew, Barraco Daniela, Lasho Terra L, Shah Sahrish, Begna Kebede H, Al-Kali Aref, Hogan William J, Litzow Mark R, Hanson Curtis A, Ketterling Rhett P, Gangat Naseema, Pardanani Anime |
WT1 gene is overexpressed in myeloproliferative neoplasms, especially in myelofibrosis. Blood cells, molecules & diseases 2019 1 75 35-40. Cottin Laurane, Riou Jérémie, Boyer Françoise, Bouvier Anne, Zannetti Alain, Blouet Anaïse, Truchan-Graczyk Matgorzata, Jouanneau-Courville Rébecca, Beucher Annaëlle, Ribourtout Bénédicte, Orvain Corentin, Hunault-Berger Mathilde, Blanchet Odile, Ugo Valérie, Luque Paz Dami |
[Analysis of gene mutations and clinic features in 108 patients with myeloproliferative neoplasm]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2020 8 41 (7): 576-582. Tan Y X, Xu N, Huang J X, Wu W E, Liu L, Zhou L L, Liu X L, Yin C X, Xu D, Zhou |
Correlation Between PAI-1 Gene 4G/5G Polymorphism and the Risk of Thrombosis in Ph Chromosome-Negative Myeloproliferative Neoplasms. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 0 26 1076029620935207. Zhang Xueya, Cai Xuerong, Pan Jingx |
Screening and diagnosis of heparin-induced thrombocytopenia in the pediatric population: A tertiary centre experience. Thrombosis research 2021 9 207 1-6. Chok Rozalyn, Turley Elona, Bruce Ais |
Portal vein thrombosis: A concise review (Review). Experimental and therapeutic medicine 2021 5 22 (1): 759. Costache Raluca S, Dragomiric? Andreea S, Dumitra? Elena A, Mariana Jinga, C?runtu Ana, Popescu Andrada, Costache Daniel |
Characterization of CRLF2 Expression in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia. Clinical laboratory 2021 1 67 (1): . Rasekh Eman O, Atef Asmaa M, Khalil Mohamed, Ebeid Emad, Madney Youssef, Hamdy Naye |
Triple-Negative Primary Myelofibrosis: A Bone Marrow Pathology Group Study. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2023 2 36 (3): 100016. Al-Ghamdi Yahya A, Lake Jonathan, Bagg Adam, Thakral Beenu, Wang Sa A, Bueso-Ramos Carlos, Masarova Lucia, Verstovsek Srdan, Rogers Heesun J, Hsi Eric D, Gralewski Jonathon H, Chabot-Richards Devon, George Tracy I, Rets Anton, Hasserjian Robert P, Weinberg Olga K, Parilla Megan, Arber Daniel A, Padilla Osvaldo, Orazi Attilio, Tam Way |
JAK2V617F Mutation and Associated Chromosomal Alterations in Primary and Secondary Myelofibrosis and Post-HCT Outcomes. Blood advances 2023 11 . Maryam Rafati, Derek Brown, Weiyin Zhou, Kristine M Jones, Wen Luo, Andrew St Martin, Youjin Wang, Meilun He, Stephen R Spellman, Tao Wang, H Joachim Deeg, Vikas Gupta, Stephanie J Lee, Yung-Tsi Bolon, Stephen J Chanock, Mitchell J Machiela, Wael Saber, Shahinaz M Gadal |
- Page last reviewed:Feb 1, 2024
- Content source: